OniX OnPoint Issue #26: Breaking Ground in Alzheimer's Research: From Bench to Bedside

New Pathways and Promising Therapeutics Transform the Fight Against Neurodegeneration

Summary of OniX OnPoint - Issue 26, Week 3 2025.

About OniX

OniX Hub provides a powerful ecosystem connecting pharmaceutical companies, venture capital firms, family offices, and biotech organizations with promising innovations. Through deep insights derived from monitoring 100K+ startups across 50+ countries, analyzing 37M+ publications, 600K+ clinical trials, and 150M+ patents, OniX facilitates strategic partnerships tailored to market needs. Our consulting services help organizations: connect with partners seeking university innovations, access targeted funding opportunities, engage with industry leaders for startup growth, and make informed decisions about technology commercialization. With a proven track record in advancing rare disease therapeutics, vaccines, nutraceuticals, and Animal Health assets—often serving as cost-effective proof of concept for human applications—OniX continues to drive successful innovation and commercialization across the life sciences.